These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 102245

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
    Sobel JD, Levison ME, Kaye D.
    Infection; 1980; 8(3):121-2. PubMed ID: 6448229
    [Abstract] [Full Text] [Related]

  • 3. Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins.
    Wise R, Gillett AP, Andrews JM, Bedford KA.
    Antimicrob Agents Chemother; 1978 Apr; 13(4):559-65. PubMed ID: 96726
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibiotics.
    Gootz TD, Sanders CC, Sanders WE.
    Antimicrob Agents Chemother; 1979 Jun; 15(6):783-91. PubMed ID: 475364
    [Abstract] [Full Text] [Related]

  • 5. A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics.
    Wise R, Gillett AP, Andrews JM.
    Clin Ther; 1980 Jun; 3(Spec Issue):149-55. PubMed ID: 6446391
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms.
    Verbist L.
    Antimicrob Agents Chemother; 1979 Aug; 16(2):115-9. PubMed ID: 485123
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL, Lewis RP, Meyer RD.
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
    Stamm JM, Hanson CW, Chu DT, Bailer R, Vojtko C, Fernandes PB.
    Antimicrob Agents Chemother; 1986 Feb; 29(2):193-200. PubMed ID: 3087274
    [Abstract] [Full Text] [Related]

  • 15. Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.
    Wise R, Andrews JM, Bedford KA.
    J Antimicrob Chemother; 1980 Mar; 6(2):197-206. PubMed ID: 6247316
    [No Abstract] [Full Text] [Related]

  • 16. [In vitro studies with piperacillin. Effectiveness against enterobacteriaceae and pseudomonas aeruginosa compared to other antibiotics (author's transl)].
    Baier R, Puppel H.
    Med Klin; 1979 Dec 14; 74(50):1923-7. PubMed ID: 120489
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.